The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections
- 8 December 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 36 (1) , 35-48
Abstract
Purpose of review: There are an estimated 374 million new sexually transmitted infections (STIs) worldwide every year. Our review article examines the current evidence of how STI acquisition, transmission, and pathogenesis is impacted upon by the genital microbiota, with a focus on epidemiological, biochemical, and immunological features. Recent findings: At least in women, a genital microbiota dominated by lactobacilli has long been considered optimal for reproductive health, while depletion of lactobacilli may lead to a genital microenvironment dominated by anaerobic pathogens, which can manifest clinically as bacterial vaginosis. Recent research efforts have characterized genital microbiota composition in greater resolution, sometimes at species-level, using proteomics, metabolomics, and deep sequencing. This has enhanced our understanding of how specific microbiota members influence acquisition or clinical manifestation of STI pathogen infection. Other advances include a steady, though still slow, increase in the number of studies that sought to determine the genital (penile or urethral) microbiota of males and how it may impact that of their female partners’ genital microbiota and risk of STI acquisition. Altogether, these data enabled us to explore the concept that genital microbiota may be sexually transmitted and influence pathogenesis and clinical presentation of other STI. Summary: With STI infection rates increasing worldwide, it is important now more than ever to find novel STI prevention strategies. Understanding if and how the genital microbiota is a modifiable risk factor for STI transmission, acquisition, and clinical manifestation may prove to be an important strategy in our efforts to curb morbidity in at risk populations.Keywords
This publication has 140 references indexed in Scilit:
- Bacterial Vaginosis and Risk for Trichomonas vaginalis Infection: A Longitudinal AnalysisSexually Transmitted Diseases, 2011
- Bacterial Vaginosis Assessed by Gram Stain and Diminished Colonization Resistance to Incident Gonococcal, Chlamydial, and Trichomonal Genital InfectionThe Journal of Infectious Diseases, 2010
- Vaginal microbiome of reproductive-age womenProceedings of the National Academy of Sciences of the United States of America, 2010
- Male Circumcision Decreases Acquisition and Increases Clearance of High‐Risk Human Papillomavirus in HIV‐Negative Men: A Randomized Trial in Rakai, UgandaThe Journal of Infectious Diseases, 2010
- Adult Male Circumcision Does Not Reduce the Risk of IncidentNeisseria gonorrhoeae, Chlamydia trachomatis,orTrichomonas vaginalisInfection: Results from a Randomized, Controlled Trial in KenyaThe Journal of Infectious Diseases, 2009
- Male Circumcision for the Prevention of HSV-2 and HPV Infections and SyphilisNew England Journal of Medicine, 2009
- The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, UgandaAmerican Journal of Obstetrics and Gynecology, 2009
- Bacterial vaginosis and HIV acquisition: a meta-analysis of published studiesAIDS, 2008
- Epidemiology and causes of preterm birthThe Lancet, 2008
- A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseasesAmerican Journal of Obstetrics and Gynecology, 2007